Coloplast A/S Share Price

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Copenhagen 08:29:35 17/05/2024 pm IST 5-day change 1st Jan Change
850 DKK +1.07% Intraday chart for Coloplast A/S +0.57% +10.10%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 27.04B 3.94B 328B Sales 2025 * 29.41B 4.28B 357B Capitalization 191B 27.84B 2,317B
Net income 2024 * 5.24B 764M 63.55B Net income 2025 * 6.12B 891M 74.17B EV / Sales 2024 * 7.79 x
Net Debt 2024 * 19.4B 2.83B 235B Net Debt 2025 * 17.9B 2.61B 217B EV / Sales 2025 * 7.11 x
P/E ratio 2024 *
36.6 x
P/E ratio 2025 *
31.3 x
Employees 15,930
Yield 2024 *
2.39%
Yield 2025 *
2.59%
Free-Float 58.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.07%
1 week+0.57%
Current month+0.43%
1 month-6.18%
3 months-3.98%
6 months+14.03%
Current year+10.10%
More quotes
1 week
826.60
Extreme 826.6
856.40
1 month
804.00
Extreme 804
929.20
Current year
757.80
Extreme 757.8
977.60
1 year
689.20
Extreme 689.2
977.60
3 years
689.20
Extreme 689.2
1 194.00
5 years
689.20
Extreme 689.2
1 194.00
10 years
413.10
Extreme 413.1
1 194.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 01/08/01
Director of Finance/CFO 52 01/06/01
Chairman 65 01/88/01
Members of the board TitleAgeSince
Director/Board Member 76 01/68/01
Director/Board Member 60 01/17/01
Chairman 65 01/88/01
More insiders
Date Price Change Volume
17/24/17 850 +1.07% 245,570
16/24/16 841 +0.43% 162,677
15/24/15 837.4 +0.29% 262,715
14/24/14 835 -1.07% 250,501

Delayed Quote Nasdaq Copenhagen, May 17, 2024 at 08:29 pm IST

More quotes
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
850 DKK
Average target price
912.3 DKK
Spread / Average Target
+7.33%
Consensus
  1. Stock Market
  2. Equities
  3. COLO B Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW